New study finds advanced liver cancer patients live longer by taking anti-cancer drug sorafenib

July 24, 2008

Researchers at Mount Sinai School of Medicine in New York have found that sorafenib (Nexavar) helps patients with advanced liver cancer live about 44 percent longer compared with patients who did not receive the anti-cancer drug. The findings, published in the July 23rd, 2008 issue of the New England Journal of Medicine, is a significant advance in the management of liver cancer, which is the third cause of cancer death globally, often resulting in death within a year of diagnosis.

"This is the first time that we've had an effective systemic treatment for liver cancer," said Josep Llovet, MD, Director of Research in Liver Cancer at Mount Sinai School of Medicine in New York, and a Professor at the Barcelona Clinic Liver Cancer (BCLC) Group in Barcelona, Spain and lead author of the study. "Our findings demonstrated survival advantages that are both statistically significant and clinically meaningful."

Sorafenib, a tablet that is taken orally, is approved in the United States for treating a form of advanced kidney cancer, and is currently being evaluated in patients with other cancers. Some 40 percent of liver cancers (and up to 80 percent in Asia and sub-Saharan Africa) are diagnosed at an advanced stage. Therapy for advanced liver cancer may include surgery (if possible), radiation therapy and/or regional chemotherapy (delivered directly into the liver). However, no systemic treatment-anti-cancer medication that enters the bloodstream, either as an oral or intravenous medicine-has proven effective to date for advanced liver cancer.

Dr. Llovet and his associates examined overall survival and the time it took for cancer to grow among patients with previously untreated liver cancer who were randomly assigned to receive either 400 mg of sorafenib twice daily (299 patients) or a placebo (303 patients).

Patients who received sorafenib lived a median of 10.7 months compared with 7.9 months for those who received a placebo. Time to cancer progression was also significantly longer in the treatment group: 5.5 vs. 2.8 months. Due to the positive findings, the study was terminated early.

The incidence of adverse side effects was similar between the two groups (52 percent in the sorafenib group and 54 percent for placebo). The most common moderate to serious side effects were diarrhea (11 percent vs. 2 percent), skin reactions in the hands and feet (8 percent vs. 1 percent), fatigue (10 percent vs. 15 percent) and bleeding (6 percent vs. 9 percent).

The Mount Sinai Hospital / Mount Sinai School of Medicine

---

---

	100 Q&A About Liver Cancer, Second Edition (100 Questions & Answers about . . .) by Ghassan K. Abou-Alfa (Author), Ronald DeMatteo (Author) EMPOWER YOURSELF! Whether you're a newly diagnosed liver cancer patient, a survivor, or a friend or relative of either, this book offers help. The only text to provide the doctor's and patient's/caregiver's views, 100 Questions & Answers About Liver Cancer gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, sources of support, and much more. Written by a medical oncologist and a gastrointestinal surgeon, with actual patient/caregiver commentary, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease.
	Liver Cancer: Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Liver Cancer - Revised Edition - Illustrated by S. Smith by Department of Health and Human Services (Author), National Institutes of Health (Author), S. Smith (Editor), S. Smith (Editor) This Liver Cancer Book is the revised version of the popular original version titled " Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Liver Cancer ", written by the: U.S. Department of Health and Human Services (Author), National Institute of Mental Health (Author), (Author), National Institutes of Health (Author) and S.Smith (Editor) and (Illustrator) This book has been professionally illustrated and edited with a fully hyper-linked table of contents for ease of navigation. A detailed booklet that describes Causes, Symptoms, Signs, Diagnosis, Treatments, Stages of Liver Cancer, with information on getting help and coping. This booklet is also for family and friends that are looking for further understanding of Liver Cancer. You will learn in this Booklet: About This Booklet...
	Defeat Cancer: 15 Doctors of Integrative & Naturopathic Medicine Tell You How by Connie Strasheim (Author), 13 Cancer Doctors (Author), Richard Linchitz MD (Introduction), Robert Rowen MD (Introduction) ONE-ON-ONE WITH 15 CANCER DOCTORS: If you traveled the world for appointments with fifteen cancer doctors, you would discover many of the cutting-edge treatments used to heal the body from cancer. You would also spend thousands of dollars on hotels, plane tickets, and medical appointment fees-not to mention the time that it would take to embark on such a journey. Even if you had the time and money to travel, would the physicians have enough time to answer all of your questions? Would you even know which questions to ask? In this long-awaited book, health care journalist Connie Strasheim has done all the work for you. She conducted intensive interviews with fifteen highly regarded doctors who specialize in cancer treatment, asking them thoughtful, important...
	Malignant Liver Tumors: Current and Emerging Therapies by Pierre-Alain Clavien (Editor), Stefan Breitenstein (Editor), Jacques Belghiti (Editor), Ravi S. Chari (Editor), Josep M. Llovet (Editor), Chung-Mau Lo (Editor), Michael A. Morse (Editor), Tadatoshi Takayama (Editor), Jean-Nicolas Vauthey (Editor) This comprehensive and critical review of current and established treatment modalities for malignant liver tumors is designed to help you sort through the proliferation of competitive approaches and choose the best treatment options for your patient. Dr. Clavien and his contributors consider all the options – radiological, surgical, pharmaceutical, and emerging/novel therapies – and help you find the best single or combined therapy.Building on the success of the previous edition, this extremely thorough revision:features a new section on Guidelines for Liver Tumors, where you will find specific strategies for treating common liver malignancies; the guidelines were prepared by the Associate Editors and take into account national and international society guidelinesreflects actual...
	What You Need To Know About: Liver Cancer This booklet is about cancer that starts in the liver (primary liver cancer). Each year in the United States, about 15,000 men and 6,000 women are told they have primary liver cancer. Most are over 64 years old. Learning about medical care for liver cancer can help you take an active part in making choices about your care. This booklet tells about diagnosis and staging, treatment and supportive care and taking part in research studies.
	100 Questions & Answers About Liver Cancer by Ghassan K. Abou-Alfa (Author), Ronald DeMatteo (Author) Whether You're A Newly Diagnosed Patient, Survivor, Or Loved One Of Someone Suffering From Liver Cancer, 100 Questions & Answers About Liver Cancer, Third Edition Offers Essential And Practical Guidance. Providing Both Doctor And Patient Perspectives, This Completely Updated And Revised Edition Offers Authoritative Answers To The Most Commonly Asked Questions About Liver Cancer Including Diagnosis, Treatment, Post-Treatment Quality Of Life, And Coping Strategies. Written By A Medical Oncologist And A Gastrointestinal Surgeon, With Actual Patient Commentary, 100 Questions & Answers About Liver Cancer, Third Edition Is An Invaluable Resource For Anyone Coping With The Physical And Emotional Turmoil Of This Disease.
	Cancer SACKED! The True Story of How Don Martin Defeated "Terminal" Cancer in 4 Months by Rediscovering a Lost Cure--and You Can Too! For those who seek sensational, exaggerated, or preposterous “cure-all” stories—this book IS NOT for you! If however, you seek simple truth and genuine hope for yourself or a loved one stricken with a long, almost certain, death sentence—then this TRUE STORY of how Don Martin cured his “terminal cancer” IS for you! Within these pages, you will learn how a wonderful cancer-cure was “mysteriously lost” from humanity--only to be "discovered" 4 more times! CANCER SACKED raises the question: “How can poisoning, burning, and slashing a person, restore them back to health?” Envision the family struggling to find hope for a suffering loved one. Is this why they call it “cancer treatment” rather than “cancer cure?” Which should be the goal?...
	Liver Cancer: Your Way Forward by Abaco Publishing You will never cure anything if you don’t do something about the underlying cause. This applies to every illness including liver cancer. In my book ‘Liver Cancer – Your way forward’ I explain why it may have developed, giving you something to do to change the underlying causes and bring things under control. As your liver takes most of the blood from your intestines, it is likely that you have eaten or drunk something that it couldn’t handle properly, combined with general bad eating habits, a poor immune system, infections, too many antibiotics, toxic chemicals, geopathic stress and certainly stresses of everyday life affecting your emotions. When cancer declares itself, it could have been developing for ten or fifteen years. All of this is explained to you in detail as though...
	Primary Liver Cancer: Surveillance, Diagnosis and Treatment (Clinical Gastroenterology) by Nancy Reau (Editor), Fred F. Poordad (Editor) Primary Liver Cancer: Surveillance, Diagnosis and Treatment focuses on the many therapies rapidly evolving to assist with controlling hepatocellular carcinoma as well as emerging technologies to assist in early diagnosis as well as prevention. All chapters are written by experts in their fields and include the most up to date information for diagnosis, treatment, surveillance, epidemiology, staging, recurrence and prevention. This volume will serve as a useful resource for clinical gastroenterologists, hepatologists, oncologists, pathologists, and physicians who treat patients with chronic liver disease and hepatocellular carcinoma.
	Dx/Rx: Liver Cancer (Dx/Rx Oncology) by Ghassan K. Abou-Alfa (Author), Celina Ang (Author) Dx/Rx: Liver Cancer Is A Quick And Practical Reference Guide Containing All Aspects Of The Diagnosis And Therapy Of Hepatocellular Carcinoma (HCC), Prognostic And Staging Systems, Clinical Management, Molecular Biology, Current Controversies, And Future Insights. Organized Into A Condensed, Bulleted Format, This Concise Reference Offers Precise And Up-To-Date Information On The Epidemiology, Classification, Diagnosis, Treatment, And Risk Factors For Cancers Of The Liver. Presented In A Handy, Easy-To-Read Format, Dx/Rx: Liver Cancer Is A Must-Have Resource For Oncologists, Internists, Primary Care Physicians, And Other Health Care Professionals On The Ward Or In The Clinic.